Mindesta Inc.

• Mindesta Inc.: Ex-Dividende-Datum von Regulierungsbehörde noch nicht festgelegt

  Mindesta Inc. meldete gestern, dass die Regulierungsbehörde U.S. Financial Industry Regulatory Authority noch keinen Ex-Dividende-Tag für die Ausgabe der Stammaktien von Northern Graphite Corporation, die sich in Besitz von Mindesta befinden, festgelegt hat, da die Überprüfung noch nicht abgeschlossen wurde. Aktionäre, die ihre Mindesta-Stammaktien nach dem 05. Januar, aber vor dem Ex-Dividende-Datum verkaufen, haben [...]

  weiterlesen

  04.01.2012

  von Redaktion
• Industrial Minerals Inc.: Namensänderung zu Mindesta Inc. und Aktiendividende

  Mindesta ist ein Explorationsunternehmen, dem noch 26,2% der ausstehenden Aktien von Northern Graphite Corporation gehören. Mindesta wird diese Aktien im Verhältnis 1:1 an seine Aktionäre als Aktiendividende ausgeben. Wer am 5. Januar 2012 Aktionär von Mindesta ist, wird am 25.Januar 2012 die gleiche Anzahl Northern Graphite eingebucht bekommen. Das in Ontario ansässige Unternehmen Northern Graphite besitzt die [...]

  weiterlesen

  28.12.2011

  von Redaktion

• Phytoplant Research S.L. and CTT Announce Collaboration

  Mindesta is pleased to announce the collaboration between CTT Pharmaceutical Holdings Inc and Phytoplant Research, S.L.. Phytoplant Resesarch S.L. will provide CTT Pharmaceuticals Inc., novel unique extracts from their proprietary Cannabis varieties to manufacture novel quick dissolving oral wafers that offer the entourage therapeutic effects of the complete phytocomplex of Cannabis, for indications such as chronic [...]

  weiterlesen

  10.08.2015

  von The Newswire
• CTT Pharmaceuticals Provides Corporate Update for Shareholders

  Mindesta Inc. CTT Pharmaceuticals Inc. has issued an update from its president to shareholders. The update is as follows: To CTT Shareholders: Let me first take this opportunity to thank you for your continued interest in CTT Pharmaceuticals. Our gains have been a direct result of the continued support of shareholders like you. At this time, I would like to provide you with an update on our activities and a view [...]

  weiterlesen

  21.04.2015

  von The Newswire
• Dr. Stephen Houldsworth, Pharma-Manufacturing Expert, Joins CTT Pharmaceuticals Advisory Board

  The Board of Directors of Mindesta is pleased to announce the appointment of Dr. Stephen Houldsworth to it's advisory board of CTT Pharmaceuticals effective immediately: "I am pleased to be working with CTT in an advisory role as they work to create evidence based medicines within the Cannabis arena using their novel drug delivery systems. At a time when medical Marijuana is seeing greater acceptance into main [...]

  weiterlesen

  29.01.2015

  von The Newswire
• CTT announces eHealth SME advisory board member Michelle Hamilton-Page

  The Board of Directors of Mindesta is pleased to announce the appointment of Michelle Hamilton-Page, Digital Strategist, to the advisory board of CTT Pharmaceuticals effective immediately. "We value the addition of Ms. Hamilton-Page, as our holistic approach includes creating better adherence and safety for our future opioid based pain management products including the use of digital technology. In order to assist in [...]

  weiterlesen

  26.11.2014

  von The Newswire
• Michelle Hamilton-Page Announced as eHealth SME Board Member

  The Board of Directors of Mindesta is pleased to announce the appointment of Michelle Hamilton-Page, Digital Strategist, to the advisory board of CTT Pharmaceuticals effective immediately. "We value the addition of Ms. Hamilton-Page, as our holistic approach includes creating better adherence and safety for our future opioid based pain management products including the use of digital technology. In order to assist in [...]

  weiterlesen

  26.11.2014

  von The Newswire

weitere engl. Meldungen